The artificial intelligence in drug discovery market reached a value of USD 3.00 billion in 2022, with a projected Compound Annual Growth Rate (CAGR) of 12.2% from 2022 to 2030, leading to an estimated value of USD 7.94 billion by 2030. North America dominated the market in 2022. Key players in this market include Microsoft, Schrödinger, Inc., Cresset, IBM, Atomwise Inc., and others.
Factors driving the growth of the artificial intelligence in drug discovery market include the need for cost and time reduction, unmet medical needs, advancements in AI and machine learning, focus on personalized medicine, and collaborations and partnerships. The market study covers regions such as North America, Latin America, Europe, East Asia, and Japan, providing insights on market players, SWOT analysis, market share, revenue, pricing, and gross margin.
Additional dynamics impacting the market include the regulatory landscape, ethical considerations, skill gap and talent acquisition, integration with existing technologies, and a focus on specific disease areas. The report also outlines macro- and microeconomic factors, market definition, classification, applications, and adoption trends. For more information, interested parties can contact Fortune Business Insights for detailed insights and analysis.
Source link
Source link: https://prasaddhumal.medium.com/how-is-ai-transforming-the-drug-discovery-market-4df7d8738741?source=rss——ai-5